Latest National Cancer Institute Stories
Harvard Stem Cell Institute scientists at Massachusetts General Hospital have a potential solution for how to more effectively kill tumor cells using cancer-killing viruses.
When cancer progresses and spreads to the bone, patients often suffer debilitating pain.
Researchers have discovered a new class of proteins capable of blocking the HIV virus from penetrating T-cells, raising hope that the proteins could be adapted for use in gels or sexual lubricants to provide a potent barrier against HIV infection.
The Mesothelioma Applied Research Foundation (Meso Foundation) applauds Congress for its bipartisan support for prioritizing National Institutes of Health (NIH) funding for Fiscal Year 2015 and
NewYork-Presbyterian/Columbia University Medical Center has opened the Irving Bone Marrow Transplant Unit, a state-of-the-art facility for comprehensive bone marrow transplant (BMT) care.
VAL-083 therapy is well tolerated to date; dose limiting toxicity has not been reached after fifth cohort (20mg/m2) VANCOUVER, British Columbia and MENLO PARK, Calif., April 9, 2014 /PRNewswire/
A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented this weekend at the American Association for Cancer
By the National Cancer Institute BETHESDA, Md., April 3, 2014 /PRNewswire-USNewswire/ -- If a screening test could not only catch cancer early but also help to prevent it, could you
The Mesothelioma Applied Research Foundation (Meso Foundation) awarded Congresswomen Betty McCollum and Chellie Pingree the Bruce Vento Hope-Builder Award, for sending a letter to Dr.
Entinostat is being investigated in patients with advanced hormone receptor-positive breast cancer by the ECOG-ACRIN Cancer Research Group in its latest trial, E2112. Philadelphia,